Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outcome measures in spasticity management

S H Pierson1

  • 1Heather Hill Rehabilitation Hospital, Chardon, OH 44024, USA.

Muscle & Nerve. Supplement
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Botulinum toxin A in the treatment of spasticity: functional implications and patient selection.

Archives of physical medicine and rehabilitation·1996
Same journal

Abstracts of the VIII International Congress on Neuromuscular Diseases. July 10-15, 1994. Kyoto, Japan.

Muscle & nerve. Supplement·2013
Same journal

Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy.

Muscle & nerve. Supplement·2013
Same journal

Mouse myodystrophy (myd) mutation: refined mapping in an interval flanked by homology with distal human 4q.

Muscle & nerve. Supplement·2013
Same journal

Neurogenic FSH muscular atrophy.

Muscle & nerve. Supplement·2013
Same journal

Clinical variability of facioscapulohumeral muscular dystrophy in Russia.

Muscle & nerve. Supplement·2013
Same journal

Facioscapulohumeral muscular dystrophy in the Dutch population.

Muscle & nerve. Supplement·2013
See all related articles

Developing reliable spasticity rehabilitation measures is challenging. A combination of outcome assessments, including patient satisfaction and cost-effectiveness, can effectively track changes in spasticity management.

Area of Science:

  • Rehabilitation Medicine
  • Neurology
  • Clinical Outcomes Assessment

Background:

  • Quantifying functional outcomes like pain, mobility, and ease of care in spasticity rehabilitation presents significant challenges.
  • Validated and reliable outcome measures are crucial for evaluating treatment efficacy and patient progress.

Observation:

  • Traditional double-blind, placebo-controlled studies are the gold standard, but single-subject designs offer a practical alternative for many spasticity treatment protocols.
  • No single assessment tool can capture the multifaceted changes resulting from spasticity interventions.

Findings:

  • A comprehensive approach combining technical, functional, patient satisfaction, and cost-effectiveness measures is recommended for evaluating spasticity management.
  • The selection of assessment tools should align with the specific functional improvements anticipated from the treatment intervention.

Related Experiment Videos

Implications:

  • This review critically evaluates various assessment tools for sensitivity, reliability, validity, and ease of administration in spasticity management.
  • Effective outcome measurement is essential for optimizing treatment strategies and improving patient outcomes in spasticity rehabilitation.